6-month sequelae according to SARS-CoV-2 Ct
Lastly, we evaluated whether diagnostic SARS-CoV-2 Ct values may predict
sequelae among survivors. Patients undergoing a complete recovery were
significantly more frequent in B and C compared to A, while those still
suffering from COVID-19-related sequelae were about three times more in
A than in B or C (Tab.2).
At multivariate analysis, lower SARS-CoV-2 diagnostic Ct value
independently associated with a higher prevalence of 6-month sequelae
among COVID-19 survivors after adjusting for age, sex, number of
comorbidities, worst oxygen support required and time from disease onset
to swab (binary logistic regression p=0.021; Tab.3).